TreeWAS – Variant ID: rs17718828

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G93.3 Postviral fatigue syndrome	0.000	0.984	0.016
K01.1 Impacted teeth	0.015	0.985	0.000
G93 Other disorders of brain	0.000	0.985	0.015
C50.9 Breast, unspecified	0.015	0.985	0.000
G93.0 Cerebral cysts	0.000	0.985	0.014
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.013	0.987	0.000
G93.2 Benign intracranial hypertension	0.000	0.987	0.013
Y42.7 Androgens and anabolic congeners	0.013	0.987	0.000
G93.6 Cerebral oedema	0.000	0.987	0.013
G93.9 Disorder of brain, unspecified	0.000	0.987	0.013
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.987	0.013
Y42.0 Glucocorticoids and synthetic analogs	0.013	0.987	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.011	0.989	0.000
G93.7 Reye's syndrome	0.000	0.989	0.011
G93.5 Compression of brain	0.000	0.989	0.011
Y42.5 Other oestrogens and progestogens	0.011	0.989	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.010	0.990	0.000
Y45.0 Opioids and related analgesics	0.010	0.990	0.000
Y48 Anaesthetics and therapeutic gases	0.010	0.990	0.000
Y42.9 Other and unspecified hormone antagonists	0.010	0.990	0.000
Y42.4 Oral contraceptives	0.010	0.990	0.000
Y42.2 Antithyroid drugs	0.010	0.990	0.000
Y42.1 Thyroid hormones and substitutes	0.010	0.990	0.000
G93.4 Encephalopathy, unspecified	0.000	0.990	0.010
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.010	0.990	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.009	0.991	0.000
Y48.3 Local anaesthetics	0.009	0.991	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.009	0.991	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.008	0.991	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.008	0.991	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.008	0.992	0.000
G93.8 Other specified disorders of brain	0.000	0.992	0.008
Y44 Agents primarily affecting blood constituents	0.008	0.992	0.000
Y54.4 Loop [high-ceiling] diuretics	0.008	0.992	0.000
Y48.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.008	0.992	0.000
Y49.5 Other antipsychotics and neuroleptics	0.008	0.992	0.000
Y48.4 Anaesthetic, unspecified	0.008	0.992	0.000
Y54.8 Agents affecting uric acid metabolism	0.008	0.992	0.000
Y59 Other and unspecified vaccines and biological substances	0.008	0.992	0.000
Y58 Bacterial vaccines	0.008	0.992	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.008	0.992	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.008	0.992	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.008	0.992	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.007	0.992	0.000
Y54.3 Benzothiadiazine derivatives	0.007	0.992	0.000
Y53.4 Other laxatives	0.007	0.992	0.000
Y48.5 Therapeutic gases	0.007	0.993	0.000
Y48.1 Parenteral anaesthetics	0.007	0.993	0.000
Y48.0 Inhaled anaesthetics	0.007	0.993	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
Y54.9 Mineral salts, not elsewhere classified	0.007	0.993	0.000
Y54.7 Agents affecting calcification	0.007	0.993	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.007	0.993	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.007	0.993	0.000
Y54.0 Mineralocorticoids	0.007	0.993	0.000
Y41.5 Antiviral drugs	0.007	0.993	0.000
K01 Embedded and impacted teeth	0.007	0.993	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.007	0.993	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.007	0.993	0.000
Y45.4 Antirheumatics	0.007	0.993	0.000
Y57 Other and unspecified drugs and medicaments	0.007	0.993	0.000
Y45.1 Salicylates	0.007	0.993	0.000
Y44.5 Thrombolytic drugs	0.007	0.993	0.000
Y49.9 Psychotropic drug, unspecified	0.007	0.993	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
Y49.7 Psychostimulants with abuse potential	0.007	0.993	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.007	0.993	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.993	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
Y45.5 4-Aminophenol derivatives	0.007	0.993	0.000
Y43 Primarily systemic agents	0.007	0.993	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.006	0.993	0.000
Y41.4 Anthelminthics	0.006	0.993	0.000
Y41.3 Other antiprotozoal drugs	0.006	0.993	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.006	0.993	0.000
Y41.1 Antimycobacterial drugs	0.006	0.993	0.000
Y41.0 Sulphonamides	0.006	0.993	0.000
Y54.5 Other diuretics	0.006	0.993	0.000
Y45.8 Other analgesics and antipyretics	0.006	0.993	0.000
H71 Cholesteatoma of middle ear	0.000	0.994	0.006
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.994	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
Y53.7 Emetics	0.006	0.994	0.000
Y53.6 Antidiarrhoeal drugs	0.006	0.994	0.000
Y53.5 Digestants	0.006	0.994	0.000
Y53.3 Saline and osmotic laxatives	0.006	0.994	0.000
Y53.2 Stimulant laxatives	0.006	0.994	0.000
Y53.0 Histamine H2-receptor antagonists	0.006	0.994	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.006	0.994	0.000
Y44.7 Plasma substitutes	0.006	0.994	0.000
Y44.6 Natural blood and blood products	0.006	0.994	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.006	0.994	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.006	0.994	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.006	0.994	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.006	0.994	0.000
Y44.2 Anticoagulants	0.006	0.994	0.000
Y46.2 Hydantoin derivatives	0.006	0.994	0.000
Y49.2 Other and unspecified antidepressants	0.006	0.994	0.000
H65 Nonsuppurative otitis media	0.000	0.994	0.006
Y46.8 Antispasticity drugs	0.006	0.994	0.000
Y46.7 Anti-Parkinsonism drugs	0.006	0.994	0.000
Y46.6 Other and unspecified antiepileptics	0.006	0.994	0.000
Y46.5 Valproic acid	0.006	0.994	0.000
Y46.4 Iminostilbenes	0.006	0.994	0.000
Y46.3 Deoxybarbiturates	0.006	0.994	0.000
Y46.1 Oxazolidinediones	0.006	0.994	0.000
Y46.0 Succinimides	0.006	0.994	0.000
H65-H75 Diseases of middle ear and mastoid	0.000	0.994	0.006
H65.4 Other chronic nonsuppurative otitis media	0.000	0.994	0.006
Y53.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
Y45.2 Propionic acid derivatives	0.006	0.994	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.006	0.994	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.006	0.994	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.006	0.994	0.000
Y47.4 Bromine compounds	0.006	0.994	0.000
Y47.3 Paraldehyde	0.006	0.994	0.000
Y47.2 Chloral derivatives	0.006	0.994	0.000
Y47.1 Benzodiazepines	0.006	0.994	0.000
Y47.0 Barbiturates, not elsewhere classified	0.006	0.994	0.000
Y50.9 Central nervous system stimulant, unspecified	0.006	0.994	0.000
Y50.8 Other central nervous system stimulants	0.006	0.994	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.006	0.994	0.000
Y50.1 Opioid receptor antagonists	0.006	0.994	0.000
Y50.0 Analeptics	0.006	0.994	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.006	0.994	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
Y55.5 Anticommon cold drugs	0.006	0.994	0.000
Y55.4 Expectorants	0.006	0.994	0.000
Y55.3 Antitussives	0.006	0.994	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.006	0.994	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.006	0.994	0.000
Y55.0 Oxytocic drugs	0.006	0.994	0.000
Y58.9 Other and unspecified bacterial vaccines	0.006	0.994	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.006	0.994	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.006	0.994	0.000
Y58.5 Diphtheria vaccine	0.006	0.994	0.000
Y58.4 Tetanus vaccine	0.006	0.994	0.000
Y58.3 Plague vaccine	0.006	0.994	0.000
Y58.2 Cholera vaccine	0.006	0.994	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.006	0.994	0.000
Y58.0 BCG vaccine	0.006	0.994	0.000
Y59.9 Vaccine or biological substance, unspecified	0.006	0.994	0.000
Y59.8 Other specified vaccines and biological substances	0.006	0.994	0.000
Y59.3 Immunoglobulin	0.006	0.994	0.000
Y59.2 Protozoal vaccines	0.006	0.994	0.000
Y59.1 Rickettsial vaccines	0.006	0.994	0.000
Y59.0 Viral vaccines	0.006	0.994	0.000
D68.2 Hereditary deficiency of other clotting factors	0.006	0.994	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.994	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.006	0.994	0.000
Y57.9 Drug or medicament, unspecified	0.006	0.994	0.000
K01.0 Embedded teeth	0.005	0.994	0.000
Y43.1 Antineoplastic antimetabolites	0.005	0.994	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.994	0.006
H65.2 Chronic serous otitis media	0.000	0.995	0.005
H74 Other disorders of middle ear and mastoid	0.000	0.995	0.005
Y56.9 Topical agent, unspecified	0.005	0.995	0.000
Y56.8 Other topical agents	0.005	0.995	0.000
Y56.7 Dental drugs, topically applied	0.005	0.995	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.005	0.995	0.000
Y56.5 Ophthalmological drugs and preparations	0.005	0.995	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.005	0.995	0.000
Y56.3 Emollients, demulcents and protectants	0.005	0.995	0.000
Y56.2 Local astringents and local detergents	0.005	0.995	0.000
Y56.1 Antipruritics	0.005	0.995	0.000
Y57.7 Vitamins, not elsewhere classified	0.005	0.995	0.000
Y57.6 Other diagnostic agents	0.005	0.995	0.000
Y57.4 Pharmaceutical excipients	0.005	0.995	0.000
Y57.3 Alcohol deterrents	0.005	0.995	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
Y57.1 Lipotropic drugs	0.005	0.995	0.000
Y57.0 Appetite depressants [anorectics]	0.005	0.995	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.005	0.995	0.000
H72 Perforation of tympanic membrane	0.000	0.995	0.005
Y43.9 Primarily systemic agent, unspecified	0.005	0.995	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.005	0.995	0.000
Y43.6 Enzymes, not elsewhere classified	0.005	0.995	0.000
Y43.5 Acidifying and alkalising agents	0.005	0.995	0.000
Y43.2 Antineoplastic natural products	0.005	0.995	0.000
Y43.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
N21.0 Calculus in bladder	0.000	0.995	0.005
H70 Mastoiditis and related conditions	0.000	0.995	0.005
Y43.4 Immunosuppressive agents	0.005	0.995	0.000
N60.3 Fibrosclerosis of breast	0.000	0.995	0.005
Y57.8 Other drugs and medicaments	0.005	0.995	0.000
H65.3 Chronic mucoid otitis media	0.000	0.995	0.005
H69 Other disorders of Eustachian tube	0.000	0.995	0.005
Y52 Agents primarily affecting the cardiovascular system	0.005	0.995	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.995	0.005
F01.9 Vascular dementia, unspecified	0.005	0.995	0.000
C77.1 Intrathoracic lymph nodes	0.000	0.995	0.005
H74.0 Tympanosclerosis	0.000	0.995	0.005
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.995	0.000
H74.4 Polyp of middle ear	0.000	0.995	0.005
H65.1 Other acute nonsuppurative otitis media	0.000	0.995	0.004
H65.0 Acute serous otitis media	0.000	0.995	0.004
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.995	0.004
H68 Eustachian salpingitis and obstruction	0.000	0.995	0.004
H67 Otitis media in diseases classified elsewhere	0.000	0.995	0.004
C15.9 Oesophagus, unspecified	0.000	0.996	0.004
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
M24.1 Other articular cartilage disorders	0.004	0.996	0.000
Y57.5 X-ray contrast media	0.004	0.996	0.000
H70.9 Mastoiditis, unspecified	0.000	0.996	0.004
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.996	0.004
H74.1 Adhesive middle ear disease	0.000	0.996	0.004
H69.9 Eustachian tube disorder, unspecified	0.000	0.996	0.004
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.996	0.004
H66 Suppurative and unspecified otitis media	0.000	0.996	0.004
Y40 Systemic antibiotics	0.004	0.996	0.000
Y52.1 Calcium-channel blockers	0.004	0.996	0.000
Z80.0 Family history of malignant neoplasm of digestive organs	0.000	0.996	0.004
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.996	0.004
C44.4 Skin of scalp and neck	0.000	0.996	0.004
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.004	0.996	0.000
H72.1 Attic perforation of tympanic membrane	0.000	0.996	0.004
J38.7 Other diseases of larynx	0.000	0.996	0.004
M24.11 Other articular cartilage disorders (Shoulder region)	0.004	0.996	0.000
H70.8 Other mastoiditis and related conditions	0.000	0.996	0.004
H70.2 Petrositis	0.000	0.996	0.004
H70.1 Chronic mastoiditis	0.000	0.996	0.004
H70.0 Acute mastoiditis	0.000	0.996	0.004
O75.8 Other specified complications of labour and delivery	0.004	0.996	0.000
H69.0 Patulous Eustachian tube	0.000	0.996	0.004
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.996	0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.996	0.000
Y52.7 Peripheral vasodilators	0.003	0.996	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.996	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.996	0.000
C71.2 Temporal lobe	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
H73 Other disorders of tympanic membrane	0.000	0.996	0.003
L89.1 Stage II decubitus ulcer	0.000	0.996	0.004
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.996	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.996	0.003
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.996	0.003
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.996	0.003
H68.1 Obstruction of Eustachian tube	0.000	0.996	0.003
H68.0 Eustachian salpingitis	0.000	0.996	0.003
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.996	0.003
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.003
D48.5 Skin	0.004	0.996	0.000
M24.13 Other articular cartilage disorders (Forearm)	0.003	0.996	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.003	0.996	0.000
H72.2 Other marginal perforations of tympanic membrane	0.000	0.997	0.003
O75.7 Vaginal delivery following previous Caesarean section	0.003	0.997	0.000
H69.8 Other specified disorders of Eustachian tube	0.000	0.997	0.003
I45.1 Other and unspecified right bundle-branch block	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.997	0.003
O75 Other complications of labour and delivery, not elsewhere classified	0.003	0.997	0.000
M24.19 Other articular cartilage disorders (Site unspecified)	0.003	0.997	0.000
M24.18 Other articular cartilage disorders (Other)	0.003	0.997	0.000
M24.14 Other articular cartilage disorders (Hand)	0.003	0.997	0.000
M24.12 Other articular cartilage disorders (Upper arm)	0.003	0.997	0.000
M24.10 Other articular cartilage disorders (Multiple sites)	0.003	0.997	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.997	0.003
H66.4 Suppurative otitis media, unspecified	0.000	0.997	0.003
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.997	0.003
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.997	0.003
H66.0 Acute suppurative otitis media	0.000	0.997	0.003
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.997	0.003
M24.17 Other articular cartilage disorders (Ankle and foot)	0.003	0.997	0.000
Q21 Congenital malformations of cardiac septa	0.003	0.997	0.000
H66.3 Other chronic suppurative otitis media	0.000	0.997	0.003
I21.9 Acute myocardial infarction, unspecified	0.000	0.997	0.003
C15 Malignant neoplasm of oesophagus	0.000	0.997	0.003
R73.0 Abnormal glucose tolerance test	0.000	0.997	0.003
C15.4 Middle third of oesophagus	0.000	0.997	0.003
Q21.0 Ventricular septal defect	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.003	0.997	0.000
N21 Calculus of lower urinary tract	0.000	0.997	0.003
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.003	0.997	0.000
H73.1 Chronic myringitis	0.000	0.997	0.003
H73.0 Acute myringitis	0.000	0.997	0.003
Q21.1 Atrial septal defect	0.003	0.997	0.000
Y40.3 Macrolides	0.002	0.997	0.001
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
O75.9 Complication of labour and delivery, unspecified	0.003	0.997	0.000
O75.5 Delayed delivery after artificial rupture of membranes	0.003	0.997	0.000
O75.4 Other complications of obstetric surgery and procedures	0.003	0.997	0.000
O75.3 Other infection during labour	0.003	0.997	0.000
O75.1 Shock during or following labour and delivery	0.003	0.997	0.000
Q28 Other congenital malformations of circulatory system	0.003	0.997	0.000
H66.9 Otitis media, unspecified	0.000	0.997	0.003
Y40.8 Other systemic antibiotics	0.002	0.997	0.000
C15.5 Lower third of oesophagus	0.000	0.997	0.003
C71 Malignant neoplasm of brain	0.003	0.997	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.003	0.997	0.000
H92.1 Otorrhoea	0.000	0.997	0.003
C67.9 Bladder, unspecified	0.003	0.997	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.002	0.997	0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.003	0.997	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.997	0.002
Q21.8 Other congenital malformations of cardiac septa	0.002	0.997	0.000
Q21.4 Aortopulmonary septal defect	0.002	0.997	0.000
Q21.3 Tetralogy of Fallot	0.002	0.997	0.000
Q21.2 Atrioventricular septal defect	0.002	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.997	0.001
F01 Vascular dementia	0.002	0.997	0.000
O75.0 Maternal distress during labour and delivery	0.002	0.997	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.002	0.997	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.997	0.002
C15.3 Upper third of oesophagus	0.000	0.997	0.002
C15.2 Abdominal part of oesophagus	0.000	0.997	0.002
C15.1 Thoracic part of oesophagus	0.000	0.997	0.002
C15.0 Cervical part of oesophagus	0.000	0.997	0.002
L90.0 Lichen sclerosus et atrophicus	0.003	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.997	0.001
O75.2 Pyrexia during labour, not elsewhere classified	0.002	0.997	0.000
R40.2 Coma, unspecified	0.000	0.997	0.002
L89 Decubitus ulcer	0.000	0.998	0.002
Q25 Congenital malformations of great arteries	0.002	0.998	0.000
G57.6 Lesion of plantar nerve	0.000	0.998	0.002
N21.9 Calculus of lower urinary tract, unspecified	0.000	0.998	0.002
N21.1 Calculus in urethra	0.000	0.998	0.002
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.002
N23 Unspecified renal colic	0.000	0.998	0.002
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.002	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
Q25.6 Stenosis of pulmonary artery	0.002	0.998	0.000
M21.0 Valgus deformity, not elsewhere classified	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.998	0.002
C71.3 Parietal lobe	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.998	0.002
L89.2 Stage III decubitus ulcer	0.000	0.998	0.002
Q28.9 Congenital malformation of circulatory system, unspecified	0.002	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.002	0.998	0.000
I45.9 Conduction disorder, unspecified	0.002	0.998	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.998	0.002
Y79.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
D68 Other coagulation defects	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
N21.8 Other lower urinary tract calculus	0.000	0.998	0.002
Q27.3 Peripheral arteriovenous malformation	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
Q26 Congenital malformations of great veins	0.002	0.998	0.000
Q24 Other congenital malformations of heart	0.002	0.998	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.002	0.998	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
D70 Agranulocytosis	0.002	0.998	0.000
I63.9 Cerebral infarction, unspecified	0.000	0.998	0.002
O47.1 False labour at or after 37 completed weeks of gestation	0.002	0.998	0.000
I45 Other conduction disorders	0.002	0.998	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
Y79 Orthopaedic devices associated with adverse incidents	0.002	0.998	0.000
D25.0 Submucous leiomyoma of uterus	0.000	0.998	0.002
F01.8 Other vascular dementia	0.002	0.998	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.002	0.998	0.000
F01.2 Subcortical vascular dementia	0.002	0.998	0.000
F01.1 Multi-infarct dementia	0.002	0.998	0.000
F01.0 Vascular dementia of acute onset	0.002	0.998	0.000
M16.1 Other primary coxarthrosis	0.000	0.998	0.002
C71.9 Brain, unspecified	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
L89.3 Stage IV decubitus ulcer	0.000	0.998	0.002
Q25.9 Congenital malformation of great arteries, unspecified	0.002	0.998	0.000
Q25.8 Other congenital malformations of great arteries	0.002	0.998	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.002	0.998	0.000
Q25.5 Atresia of pulmonary artery	0.002	0.998	0.000
Q25.4 Other congenital malformations of aorta	0.002	0.998	0.000
Q25.3 Stenosis of aorta	0.002	0.998	0.000
Q25.2 Atresia of aorta	0.002	0.998	0.000
Q25.1 Coarctation of aorta	0.002	0.998	0.000
Q25.0 Patent ductus arteriosus	0.002	0.998	0.000
R73 Elevated blood glucose level	0.000	0.998	0.002
Y40.0 Penicillins	0.001	0.998	0.001
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.002	0.998	0.000
M35.3 Polymyalgia rheumatica	0.000	0.998	0.002
W20.0 Home	0.002	0.998	0.000
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.002	0.998	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.998	0.002
D48.0 Bone and articular cartilage	0.002	0.998	0.000
I45.3 Trifascicular block	0.002	0.998	0.000
W07.9 Unspecified place	0.000	0.998	0.002
I45.8 Other specified conduction disorders	0.002	0.998	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.998	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.002	0.998	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.002	0.998	0.000
Q27.4 Congenital phlebectasia	0.002	0.998	0.000
Q27.2 Other congenital malformations of renal artery	0.002	0.998	0.000
Q27.1 Congenital renal artery stenosis	0.002	0.998	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.002	0.998	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
D68.5 Primary Thrombophilia	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
M21.09 Valgus deformity, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M21.08 Valgus deformity, not elsewhere classified (Other)	0.002	0.998	0.000
M21.05 Valgus deformity, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
M21.04 Valgus deformity, not elsewhere classified (Hand)	0.002	0.998	0.000
M21.03 Valgus deformity, not elsewhere classified (Forearm)	0.002	0.998	0.000
M21.02 Valgus deformity, not elsewhere classified (Upper arm)	0.002	0.998	0.000
M21.01 Valgus deformity, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
M21.00 Valgus deformity, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
D37.4 Colon	0.000	0.998	0.002
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.002	0.998	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.002	0.998	0.000
W07.0 Home	0.000	0.998	0.002
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.002	0.998	0.000
D68.1 Hereditary factor XI deficiency	0.002	0.998	0.000
Z47.8 Other specified orthopaedic follow-up care	0.000	0.998	0.002
M24.75 Protrusio acetabuli-Pelvic/thigh	0.002	0.998	0.000
I45.2 Bifascicular block	0.002	0.998	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.002	0.998	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
Q20.6 Isomerism of atrial appendages	0.002	0.998	0.000
Q20.5 Discordant atrioventricular connexion	0.002	0.998	0.000
Q20.4 Double inlet ventricle	0.002	0.998	0.000
Q20.3 Discordant ventriculoarterial connexion	0.002	0.998	0.000
Q20.2 Double outlet left ventricle	0.002	0.998	0.000
Q20.1 Double outlet right ventricle	0.002	0.998	0.000
Q20.0 Common arterial trunk	0.002	0.998	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.002	0.998	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.002	0.998	0.000
Q22.6 Hypoplastic right heart syndrome	0.002	0.998	0.000
Q22.5 Ebstein's anomaly	0.002	0.998	0.000
Q22.4 Congenital tricuspid stenosis	0.002	0.998	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.002	0.998	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.002	0.998	0.000
Q22.1 Congenital pulmonary valve stenosis	0.002	0.998	0.000
Q22.0 Pulmonary valve atresia	0.002	0.998	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.002	0.998	0.000
Q26.8 Other congenital malformations of great veins	0.002	0.998	0.000
Q26.6 Portal vein-hepatic artery fistula	0.002	0.998	0.000
Q26.5 Anomalous portal venous connexion	0.002	0.998	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.002	0.998	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.1 Persistent left superior vena cava	0.002	0.998	0.000
Q26.0 Congenital stenosis of vena cava	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.000	0.998	0.002
I45.4 Nonspecific intraventricular block	0.002	0.998	0.000
Q24.6 Congenital heart block	0.002	0.998	0.000
Q24.5 Malformation of coronary vessels	0.002	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.002	0.998	0.000
Q24.2 Cor triatriatum	0.002	0.998	0.000
Q24.1 Levocardia	0.002	0.998	0.000
Q24.0 Dextrocardia	0.002	0.998	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.002	0.998	0.000
A09.9 Gastroenteritis and colitis of unspecified origin	0.002	0.998	0.000
I45.0 Right fascicular block	0.002	0.998	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.002	0.998	0.000
J81 Pulmonary oedema	0.002	0.998	0.000
W07 Fall involving chair	0.001	0.998	0.001
X58 Exposure to other specified factors	0.002	0.998	0.000
Y79.8 Miscellaneous devices, not elsewhere classified	0.002	0.998	0.000
Y79.3 Surgical instruments, materials and devices (including sutures)	0.002	0.998	0.000
Y79.1 Therapeutic (nonsurgical) and rehabilitative devices	0.002	0.998	0.000
Y79.0 Diagnostic and monitoring devices	0.002	0.998	0.000
M24.7 Protrusio acetabuli	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
X58.9 Unspecified place	0.002	0.998	0.000
M24 Other specific joint derangements	0.002	0.998	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.002	0.998	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.002	0.998	0.000
Y80 Physical medicine devices associated with adverse incidents	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations